Karita, M et al, The American Journal of Gastroenterology, vol. 86(11), 1991, pp. 1596-1603.* |
Clemens, c, Ophidian Pharmaceuticals, Inc. 1994, Passive Immune Therapy for Helicobacter Incection (abstract only).* |
Kim, FB et al, Korean Journal of Applied Microbiology and Biotechnology, Dec. 1997, vol. 25(6), pp. 612-616 (abstract only).* |
Kim et al., “Production and characterization of IgY specific to Helicobacter pylori,”, Korean Journal of Applied Microbiology and Biotechnology, 1997, pp. 612-616, vol. 25, No. 6 (abstract), published in the Korean Republic, Dec. 1997. |
Hassl et al., “Purification of egg yolk immunoglobulins—A two-step procedure using hydrophobic interaction chromatography and gel filtration”, Journal of Immunological Methods, 1988, pp. 225-228, vol. 110, Elsevier Science Publishers, New York, New York. |
Clyne et al., “The Urease Enzyme of Helicobacter pylori Does Not Function as an Adhesin”, Infection and Immunity, 1996, pp. 2817-2820, vol. 64, No. 7, American Society for Microbiology, Washington, D.C. |
Blanchard et al., “Urease-Specific Monoclonal Antibodies Prevent Helicobacter felis Infection in Mice”, Infection and Immunity, 1995, pp. 1394-1399, vol. 63, No. 4, American Society for Microbiology, Washington, D.C. |
Kostrzynaka, et al., “Identification, Characterization, and Spatial Localization of Two Flagellin Species in Helicobacter pylori Flagella”, Journal of Bacteriology, 1991, pp. 937-946, vol. 173, No. 3, American Society for Microbiology, Washington, D.C. |
Leying et al., “Cloning and genetic characterization of a Helicobacter pylori flagellin gene”, Molecular Microbiology, 1992, pp. 2863-2874, vol. 6, No. 19, American Society for Microbiology, Washington, D.C. |
Thomas et al., “Protection by human milk IgA against Helicobacter pylori Infection In Infancy”, LANCET, 1993, p. 121, vol. 342, No. 8863, The Lancet, United Kingdom. |
Ferrero et al., “The Importance of Urease in Acid Protection for the Gastric-colonising Bacteria Helicobacter pylori and Helicobacter felis sp. nov.”, Microbial Ecology in Health and Disease, 1991, pp. 121-134, vol. 4, Taylor & Francis, Ltd., Oxfordshire, United Kingdom. |
Pappo et al., “Effect of Oral Immunization with Recombinant Urease on Murine Helicobacter felis Gastritis”, Infection and Immunity, 1995, pp. 1246-1252, vol. 63, No. 4, American Society for Microbiology, Washington, D.C. |
Newell, “Virulence Factors of Helicobacter pylori”, Scand. J. Gastroenterol, 1991, pp. 31-38, vol. 26, No. 187, Porton Down, Salisbury, United Kingdom. |
Davin et al., “H. pylori Urease Elicits Protection against H. felis Infection in Mice”, 1993, p. A1035, (Abstract), vol. 104, No. 4. |
Hawtin et al., “Investigation of the structure and localization of the urease of Helicobacter pylori using monoclonal antibodies”, Journal of General Microbiology, 1990, pp. 1995-2000, vol. 136, No. 10, American Society for Microbiology, Washington, D.C. |
Czinn et al., “Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization”, Vaccine, 1993, pp. 637-642, vol. 11, No. 6, Elsevier, New York, New York. |
Bukanov, “Ordered cosmid library and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638”, Molecular Microbiology, 1994, p. 509-523, vol. 11(3), American Society for Microbiology, Washington, D.C. |
Malfertheiner et al., “Rationale for Eradication of Helicobacter pylori Infection in Duodenal Ulcer Disease”, Clinical Therapeutics, 1993, p. 37-48, vol. 15 (suppl B). |
Haas et al., “Aflagellated mutants of Helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis”, Molecular Microbiology, 1993, p. 753-760, vol. 8, No. 4, American Society for Microbiology, Washington, D.C. |
Blaser, “Helicobacter pylori: microbiology of a ‘slow’ bacterial infection”, Trends in Microbiology, Oct. 1993, p. 255-260, vol. 1, No. 7, Elsevier Science Publishers Ltd., United Kingdom. |
Gassmann et al., “The egg yolk—a rich source of polyclonal antibodies”, Schweiza Archivfur Tierheilkunde, 1990, pp. 289-294, vol. 132, No. 6. |
Bade et al., “Rapid method of extraction of antibodies from hen egg yolk”, J. Immunol. Methods, 1984, p. 421-426, vol. 172, No. 2, Institute fur Biochemie, Braunschweig, West Germany. |
Stacey et al., “Antigenicity of fractions of Helicobacter pylori prepared by fast protein liquid chromatograph and urease captured by monoclonal antibodies”, European Journal of Clinical Microbiology and Infectious Disease, 1990, pp. 732-737, vol. 9, NO. 10,0), Germany. |
Thomas et al., Journal of Clinical Microbiology, 1992, pp. 1338-1340, vol. 30, No. 5, (abstract). |
Nagata et al.,“Monoclonal Antibodies against the Native Urease of Helicobacter pylori: Synergistic Inhibition of Urease Activity by Monoclonal Antibody Combinations”, Infection and Immunity, 1992, pp. 4826-4831, vol. 60, No. 11, American Society for Microbiology, Washington, D.C. |
Ermak et al., “Oral Immunization of mice with recombinant Helicobacter pylori urease induces antigen specific IgA+ plasma cells and inhibits colonization of Helicobacter felis in gastric mucosa”, FASEB, 1995, p. A216, vol. 9, No. 3, The Federation of American Societies for Experimental Biology, Bethesda, Maryland. |
Zhang et al., “Study on purification of H. pylori urease antigen”, Zhonghua Weishengwuxue He Mianyixue Zazhi, 1995, pp. 344-346, vol. 5, No. 5, Published in China. |
Lee et al., “Oral immunization with recombinant Helicobacter pylori urease induces secretary IgA antibodies and protects mice from challenge with Helicobacter felis”, J. Infectious Disease, 1995, pp. 161-172, vol. 172, No. 1, WebMD Medscape Health Network, New York, New York. |
Makoto et al., “Antibody of chicken egg infectious disease prevention by oral passive immunigation”, Taiyo Kagaku, 1995, pp. 230-235, vol. 50, No. 4, Japan. |
Yokoyama et al., “Detection of passage and absorption of chicken egg yolk immunoglobulins in the gastrointestinal tract of pigs by use of enzyme-linked immunosobent assay and fluorescent antibody testing”, American Journal of Veterinary Research, 1993, pp. 867-872, vol. 54, No. 6, American Veterinary Medical Association, Chicago, Illinois. |
Otake et al., “Protection of rats against dental caries by passive immunization with hen-egg yolk antibody (IgY)”, Journal of Dental Research, 1991, pp. 162-166, vol. 70, No. 3, American Association for Dental Research, Alexandria, Virginia, U.S.A. |
Schade et al., “Polyclonal IGY Antibodies from Chicken Egg-Yolk—An Alternative to the Production of Mammalian IGG Type Antibodies in Rabbits” Atla-Alternative to Laboratory Animals, 1991, pp. 403-419, vol. 19, No. 4. |
Hadge, D, “Evolution of the Immunoglobulins”, Allergie and Immunologies, 1985, pp. 231-243, vol. 31, No. 4, Germany. |
Deignan et al., “Passive immunisation of the gastrointestinal tract with hen egg immunoglobulin” 9th International Congress of Immunology, 1995, p. 892, 9th International Congress of Immunology, San Francisco, California, U.S.A. |
Yokoyama et al., “Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets”, Infection Immunity, 1992, pp. 998-1007, vol. 60, No. 3, American Society for Microbiology, Washington, D.C. |
Hajime et al, Japanese Journal of Dairy and Food Science, 1992, pp. 217-222, vol. 41, No. 6. |
Sugiyama, “Egg as a passive immunity food”, Nogyo Gijutsu Kenkyu, pp. 86-87, figure 2, vol. 50, No. 5, Japan. |
Schmidt et al., “Chicken egg antibodies for prophylaxis and therapy of infectious intestinal diseases”, Zentralblatt fur Veterinarmedizin, 1989, pp. 619-628, vol. 36, No. 8, West Germany. |
O'Farrelly et al., “Oral Ingestion of Egg Yolk Immunoglobulin from Hens Immunized with an Enterotoxigenic Escherichia coli Strain Prevents Diarrhea in Rabbits Challenged with the Same Strain”, Infection Immunity, 1992, pp. 2593-2597, vol. 60, No. 7, American Society for Microbiology, Washington, D.C. |
Akita et al., “Production and purification of Fab'fragments from chicken egg yolk immunoglobulin Y (IgY)”, Journal Immunological Methods, 1993, pp. 155-64, vol. 162, Elsevier Science Publishers B.V., Amsterdam. |
Larsson et al., “Chicken IgY: Utilizing the Evolutionary Difference”, Comp. Immunol. Microbiol. Infect. Dis., 1990, pp. 199-201, vol. 13, No. 4, Pergamon Press, Great Britain. |
Seymour et al., “Isolation of Helicobacter Strains from Wild Bird and Swine Feces”, Applied and Environmental Microbiology, 1994, pp. 1025-1028, vol. 60, No. 3, American Society for Microbiology, Washington, D.C. |
Dewhirst et al., “Phylogeny of Helicobacter Isolates from Bird and Swine Feces and Description of Helicobacter parametensis sp. nov.”, International Journal of Systematic Bacteriology, 1994, pp. 553-560, vol. 44, No. 3, International Union of Microbiological Societies. |
Marchetti et al., “Developments of a Mouse Model of Helicobacter pylori Infection That Mimics Human Disease” Science, 1995, pp. 1655-1658, vol. 267, American Association for the Advancement of Science, Washington, D.C. |
ISSN 0002-1407, Nippon Nogiekagaku Kaishi, Mar. 1997, p. 52 (Abstract #20p22) Japan Society for Bioscience, Biotechnology, and Agrochemistry (Formerly The Agriculture Chemical Society of Japan), Japan. |
Eaton et al., “Avirulent, Urease-Deficient Helicobacter pylori Colonizes Gastric Epithelial Explants Ex Vivo”, Scand J Gastroenterol, 1995, pp. 434-437, vol. 30. |
Bhatia et al., “Lactobacillus acidophilus Inhibits Growth of Campylobacter pylori in Vitro”, Journal of Clinical Microbiology, Oct. 1989, pp. 2328-2330, vol. 27, No. 10, American Society for Microbiology, Washington, D.C. |
Midolo et al., “In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria”, Journal of Applied Bacteriology, 1995, pp. 475-479, vol. 79, The Society for Applied Bacteriology, Blackwell Publishers, Malden, MA, U.S.A. |
The Meeting of the 30th Japan Germ-free Animal Gnotobiology Society, Program and Abstracts, p. 22, (Abstract #18), Jan. 24, 1997, “New Attempt for Inhibiting Helicobacter pylori”. |
Katloff, “Helicobacter pylori and gastroduodenal disorders: new approaches for prevention, diagnosis and treatment”, Vaccine, 1996, pp. 1174-1175, vol. 14, No. 12, Elsevier, Great Britain. |
Patent Abstract of Japanese 09087297, vol. 97, No. 7, Jul. 31, 1997. |
Patent Abstract of Japanese 04275232, vol. 17, No. 67, Feb. 10, 1993. |